OXIGENE INC 4
4 · OXIGENE INC · Filed Jul 2, 2013
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-07-01+10,060→ 10,060 totalExercise: $2.70From: 2013-07-01Exp: 2019-07-01→ Common Stock (10,060 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options") pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy as partial payment for Board of Directors services to be provided during the last six months of 2013.
- [F2]The Stock Options were fully vested as of the grant date.